Abstract
Although outbreaks of Neisseria meningitidis serogroup X occured in a couple of African countries, a limited number of serogroup X meningococcal cases were reported in America and Europe as well as Turkey. Additionally, serogroup X is still not represented in current conjugated meningococcal vaccines. Here, we describe the first pediatric case with meningitis caused by Neisseria meningitidis serogroup X ST-5799 (ST-22 complex) that formed a distinct lineage.
Keywords:
Turkey; menengitis; pediatrics; phylogenetic network; sequence analyses.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / therapeutic use*
-
DNA, Bacterial / cerebrospinal fluid
-
DNA, Bacterial / isolation & purification
-
Drug Therapy, Combination / methods
-
Humans
-
Infant
-
Male
-
Meningitis, Meningococcal / diagnosis
-
Meningitis, Meningococcal / drug therapy
-
Meningitis, Meningococcal / immunology
-
Meningitis, Meningococcal / microbiology*
-
Neisseria meningitidis / genetics
-
Neisseria meningitidis / immunology*
-
Neisseria meningitidis / isolation & purification
-
Phylogeny
-
Serogroup*
-
Treatment Outcome
-
Turkey
Substances
-
Anti-Bacterial Agents
-
DNA, Bacterial